CANNANNEW REPORT

Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form … Read More… The post Canntab to Launch in Australia and Participate in Cannabis Research Study first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Canntab to Launch in Australia and Participate in Cannabis Research Study

reposted by Cannabis News World